PORTO @ Archivio Istituzionale della Ricerca

MESIANO, GIULIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 1.811
EU - Europa 1.086
NA - Nord America 913
SA - Sud America 229
AF - Africa 37
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 4.078
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 888
SG - Singapore 584
VN - Vietnam 464
IT - Italia 429
CN - Cina 318
RU - Federazione Russa 236
BR - Brasile 192
BE - Belgio 158
KR - Corea 134
HK - Hong Kong 95
FR - Francia 57
IN - India 52
DE - Germania 49
TR - Turchia 29
PT - Portogallo 27
ID - Indonesia 26
GB - Regno Unito 23
CH - Svizzera 20
AT - Austria 18
PH - Filippine 17
AR - Argentina 15
BD - Bangladesh 15
JP - Giappone 15
PL - Polonia 15
TH - Thailandia 13
CA - Canada 11
FI - Finlandia 11
IQ - Iraq 11
MA - Marocco 10
TW - Taiwan 10
NL - Olanda 9
SE - Svezia 9
MX - Messico 8
IE - Irlanda 7
CO - Colombia 6
BY - Bielorussia 5
PK - Pakistan 5
TN - Tunisia 5
AE - Emirati Arabi Uniti 4
SN - Senegal 4
VE - Venezuela 4
ZA - Sudafrica 4
CI - Costa d'Avorio 3
CL - Cile 3
EC - Ecuador 3
EG - Egitto 3
ET - Etiopia 3
JO - Giordania 3
LT - Lituania 3
UA - Ucraina 3
AZ - Azerbaigian 2
IL - Israele 2
IR - Iran 2
MY - Malesia 2
PY - Paraguay 2
UY - Uruguay 2
UZ - Uzbekistan 2
AM - Armenia 1
AO - Angola 1
AU - Australia 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BH - Bahrain 1
CR - Costa Rica 1
DK - Danimarca 1
DZ - Algeria 1
ES - Italia 1
GP - Guadalupe 1
GR - Grecia 1
GY - Guiana 1
HN - Honduras 1
JM - Giamaica 1
KE - Kenya 1
KW - Kuwait 1
KZ - Kazakistan 1
MM - Myanmar 1
MU - Mauritius 1
NG - Nigeria 1
NP - Nepal 1
PE - Perù 1
RO - Romania 1
SI - Slovenia 1
SV - El Salvador 1
TT - Trinidad e Tobago 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 4.078
Salva come PNG Salva come JPEG
Città #
Singapore 335
Turin 195
San Jose 194
Ashburn 164
Brussels 158
Ho Chi Minh City 115
Seoul 106
Hanoi 99
Hong Kong 77
Dallas 59
Council Bluffs 58
Los Angeles 58
Hefei 55
Santa Clara 55
Beijing 43
New York 40
Boardman 34
Lauterbourg 29
Milan 26
Lisbon 24
Da Nang 23
Istanbul 23
Haiphong 22
Moscow 22
Jakarta 21
Bern 20
Naples 18
The Dalles 18
Frankfurt am Main 16
São Paulo 16
Buffalo 15
Gdansk 11
Nuremberg 11
Paris 11
Rio de Janeiro 11
Munich 10
Rome 10
Tokyo 10
Miami 9
Bangkok 8
Cosenza 8
Biên Hòa 7
Dublin 7
Genoa 7
Hải Dương 7
Long Xuyen 7
Redondo Beach 7
Arezzo 6
Guangzhou 6
London 6
Mumbai 6
Phoenix 6
Shanghai 6
Vienna 6
Buenos Aires 5
Curitiba 5
Denver 5
Lappeenranta 5
Salvador 5
Taipei 5
Agadir 4
Ankara 4
Bruino 4
Cangzhou 4
Chennai 4
Cicciano 4
Dakar 4
Florence 4
Livorno Ferraris 4
Nha Trang 4
Novara 4
Orem 4
Ottawa 4
Porto Alegre 4
Sassari 4
Stockholm 4
Thái Nguyên 4
Yubileyny 4
Điện Bàn 4
Abidjan 3
Addis Ababa 3
Atlanta 3
Baghdad 3
Blumenau 3
Boston 3
Brescia 3
Bình Phước 3
Bắc Ninh 3
Cairo 3
Cebu City 3
Charlotte 3
Columbus 3
Cormeilles-en-Parisis 3
Goiânia 3
Helsinki 3
Karbala 3
Luni 3
Makati City 3
Manila 3
Milwaukee 3
Totale 2.490
Salva come PNG Salva come JPEG
Nome #
The Multifunctional Purposes of Ultrasound in 3D Models 290
Anti-CD38 targeted nanotrojan horses stimulated by acoustic waves as therapeutic nanotools selectively against Burkitt’s lymphoma cells 280
Acoustic waves and smart biomimetic nanoparticles: combination treatment from 2 to 3D colorectal cancer models 251
Targeted lipid-coated ZnO nanoparticles coupled with ultrasound: a sonodynamic approach for the treatment of osteosarcoma as 3D spheroid models 205
Artificial and Naturally Derived Phospholipidic Bilayers as Smart Coatings of Solid-State Nanoparticles: Current Works and Perspectives in Cancer Therapy 194
Effective combination of biocompatible zinc oxide nanocrystals and high-energy shock waves for the treatment of colorectal cancer 187
Lenalidomide normalizes tumor vessels in colorectal cancer improving chemotherapy activity 133
CSPG4 as innovative target for CAR redirected CIK lymphocytes against soft tissue sarcomas 127
Ex vivo-activated MHC-unrestricted immune effectors for cancer adoptive immunotherapy 127
Anti-CSPG4 CAR.CIK lymphocytes are effective against advanced sarcomas in 3D spheroid and xenograft models 127
CD44v6 as innovative sarcoma target for CAR-redirected CIK cells 126
Explorative model of imatinib resistant wild type GIST and potential immunotherapy strategies 125
CSPG4-Specific CAR.CIK Lymphocytes as a Novel Therapy for the Treatment of Multiple Soft-Tissue Sarcoma Histotypes 118
Cytokine-Induced Killer (CIK) Cells, In Vitro Expanded under Good Manufacturing Process (GMP) Conditions, Remain Stable over Time after Cryopreservation 117
Cytokine-induced killer cells kill chemo-surviving melanoma cancer stem cells 115
Cytokines induced killer cells produced in good manufacturing practices conditions: identification of the most advantageous and safest expansion method in terms of viability, cellular growth and identity 113
EphA2 Expression in Bone Sarcomas: Bioinformatic Analyses and Preclinical Characterization in Patient-Derived Models of Osteosarcoma, Ewing's Sarcoma and Chondrosarcoma 108
Preclinical immunotherapy with Cytokine-Induced Killer lymphocytes against epithelial ovarian cancer 106
Cytokine Induced Killer cells are effective against sarcoma cancer stem cells spared by chemotherapy and target therapy 102
Integrated Antitumor Activities of Cellular Immunotherapy with CIK Lymphocytes and Interferons against KIT/PDGFRA Wild Type GIST 102
Immunotherapy of cancer stem cells in solid tumors: Initial findings and future prospective 100
Correction to: Cytokines induced killer cells produced in good manufacturing practices conditions: identification of the most advantageous and safest expansion method in terms of viability, cellular growth and identity 95
Genetically redirected T lymphocytes for adoptive immunotherapy of solid tumors 88
Effective activity of cytokine-induced killer cells against autologous metastatic melanoma including cells with stemness features 85
Analytic and Dynamic Secretory Profile of Patient-Derived Cytokine-Induced Killer Cells 84
Adoptive immunotherapy against sarcomas 81
Activity of cytokine-induced killer cells against bone and soft tissue sarcoma 80
Cytokine-induced killer (CIK) cells as feasible and effective adoptive immunotherapy for the treatment of solid tumors 79
Specific Monoclonal Antibody Against Bcr/Abl Out-of-Frame Alternative Proteins as Diagnostic Tool in Chronic Myelogenous Leukemia Patients 78
Cytokine induced killer cells as adoptive immunotherapy strategy to augment graft versus tumor after hematopoietic cell transplantation 78
Transient proteasome inhibition as a strategy to enhance lentiviral transduction of hematopoietic CD34 + cells and T lymphocytes: Implications for the use of low viral doses and large-size vectors 78
Cytokine-induced killer cells eradicate bone and soft-tissue sarcomas 73
Ex vivo allogeneic stimulation significantly improves expansion of cytokine-Induced killer cells without increasing their alloreactivity across HLA barriers 72
The cGAS-STING pathway is a master regulator of OCT4 expression in persistent sarcoma cells and enhances cellular immunotherapy with NK and CIK lymphocytes 61
Totale 4.185
Salva come PNG Salva come JPEG
Categoria #
all - tutte 11.853
article - articoli 11.853
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 23.706
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/2023236 0 0 0 0 0 17 8 144 10 26 3 28
2023/2024254 3 35 14 17 9 41 17 23 17 11 31 36
2024/20251.140 38 106 171 159 86 34 65 47 131 45 83 175
2025/20262.555 226 175 207 232 152 132 380 220 541 251 39 0
Totale 4.185